Takahashi T, Svoboda K, Malinow R (2003)
For patients with Type 2 Diabetes, Semaglutide improves insulin secretion in a glucose-dependent manner, lowering blood sugar levels without the high risk of hypoglycemia
The study was divided into two cohorts: the first compared users of GLP-1RAs with users of DPP-4is, and the second compared users of GLP-1RAs with users of SGLT-2is
#DiabetesCare #Pharma #Pharmacology #DiabetesAwareness #Gliptins #MechanismOfAction #Onpharma To view or add a comment, sign in More Relevant Posts WHY NASAL DELIVERY OF GLP-1 PEPTIDES? In contrast to the oral and subcutaneous routes of administration, nasal delivery of GLP-1 peptide drugs provides unique advantages: The nasal mucosal environment is less acidic, less digestive, and simpler to use than the oral delivery route
Health science literacy, meaning the ability to engage substantively with nutrition, physiology, and pharmaceutical data and convert that engagement into commercial decisions, should be an explicit criterion in CPS CEO mandates where portfolio exposure is material